Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term T-cell prolymphocytic leukaemia
ADR ID BADD_A11011
ADR Hierarchy
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.11      Leukaemias chronic T-cell
01.10.11.002      T-cell prolymphocytic leukaemia
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.11      Leukaemias chronic T-cell
16.01.11.002      T-cell prolymphocytic leukaemia
Description A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia. [MeSH]
MedDRA Code 10042985
MeSH ID D015461
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
T-cell prolymphocytic leukaemia | T-cell prolymphocytic leukemia | Leukemia, Prolymphocytic, T-Cell | T-Cell Prolymphocytic Leukemia | Leukemia, T-Cell Prolymphocytic | Leukemias, T-Cell Prolymphocytic | Prolymphocytic Leukemia, T-Cell | Prolymphocytic Leukemias, T-Cell | T Cell Prolymphocytic Leukemia | T-Cell Prolymphocytic Leukemias | Leukemia, T Cell, Chronic | Lymphocytic Leukemia, T Cell, Chronic | Leukemia, Lymphocytic, Chronic, T-Cell | T-Lymphocytic Leukemia, Chronic | T-Cell Leukemia, Chronic | Leukemia, T-Cell, Chronic | Leukemia, Lymphocytic, Chronic, T Cell | Lymphocytic Leukemia, T-Cell, Chronic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01978Ruxolitinib0.000137%
BADD_D02345Venetoclax0.000224%
The 1th Page    1    Total 1 Pages